{"id":212399,"name":"WE WORK FOR HEALTH","slug":"we-work-for-health","state":"DC","country":"United States of America","description":"Biopharmaceutical advocacy and educational outreach","totalSpending":70000,"filings":8,"yearlySpending":[{"year":2021,"income":20000},{"year":2022,"income":50000}],"issues":[{"code":"MED","display":"Medical/Disease Research/Clinical Labs"},{"code":"HCR","display":"Health Issues"},{"code":"MMM","display":"Medicare/Medicaid"}],"firms":["JUNTO SOLUTIONS, LLC"],"lobbyists":["ELIZABETH DUTHIE"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Biopharmaceutical issues including: social and economic, value of biopharmaceutical sector, patient access and safety issues, drug importation, life science innovation, job impact.","Biopharmaceutical issues including: social and economic, value of biopharmaceutical sector, patient access and safety issues, drug importation, life science innovation, job impact.","Biopharmaceutical issues including: social and economic, value of biopharmaceutical sector, patient access and safety issues, drug importation, life science innovation, job impact.","Integrity of Medicare Part D Part B and the Affordable Care Act Public Law No: 111-148; H.R. 3 - Lower Drug Costs Now Act","Integrity of Medicare Part D Part B and the Affordable Care Act Public Law No: 111-148; H.R. 3 - Lower Drug Costs Now Act"]}